Interpace Biosciences stockholders approve 2026 equity incentive plan and ESPP

INTERPACE BIOSCIENCES, INC.

Stockholders approved 2026 Equity Incentive Plan and 2026 ESPP at Aug 20, 2026 annual meeting.
New plans replace 2019 Equity Incentive Plan and 2019 ESPP; no further grants or purchases under old plans.
Material terms previously disclosed in proxy statement filed July 7, 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.